United States-based Pfizer is opening a new manufacturing facility in Andover, Massachusetts, it was reported yesterday.
The facility covers a 175,000 square-foot area. It accommodates commercial manufacturing and product development functions for the development and production of complex biologics and vaccines. The site will offer 75 new jobs for the Andover area economy, adding to the around 2,000 staff currently based in Massachusetts.
The newly opened Andover Clinical Manufacturing Facility will expand the capacity for Pfizer's BioTherapeutics Pharmaceutical Sciences organization to manufacture clinical supplies. The company's ACMF investment is more than USD200m and includes five independent manufacturing suites, with more than 50 projects currently in development.
Wasatch BioLabs adds three Oxford Nanopore-developed research-use-only assays to service portfolio
GSK and IQVIA expand vaccine track with local data to drive targeted public health action
AstraZeneca launches online platform to expand patient access to medications
Sanofi increases Sanofi Ventures funding by USD625m to boost biotech and digital health investments
GC Biopharma submits IND application in South Korea for Phase 1 trial of COVID-19 vaccine candidate
AusperBio completes patient enrolment in two Phase II clinical trials of AHB-137
LakeShore Biopharma receives Nasdaq delisting determination letter